Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 531
Selected: 0
NCT IDTitle
NCT03349762Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
NCT01238562Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT06405269Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
NCT03772496Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)
NCT01637493Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
NCT02988921MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy
NCT06808971Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ
NCT02053948Pursestring Wound Closure vs "Gunsight" Skin Incision and Closure Technique to Reverse Stoma
NCT03214003Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC
NCT02989259Apatinib for Advanced Non-squamous Head and Neck Cancer
NCT06114420Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT02646735Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
NCT03308552Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
NCT06958614Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC
NCT06255912Clinical Trial for Advanced or Metastatic Pancreatic Cancer
NCT05188859First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
NCT05524389Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
NCT06752148Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients
NCT07200947A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
NCT06655285The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
NCT07486648Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT05009017Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients
NCT04443478Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT03298204Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
NCT07376538Response-Based Local Therapy for Regionally Advanced Breast Cancer
NCT04024696A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients
NCT04769388Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib
NCT06051760NV-001 in the Treatment of Advanced Solid Tumors
NCT02861196Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
NCT01413269Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery
NCT06492629Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma
NCT07461727An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases
NCT03356236Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation
NCT04822792Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT
NCT06490068Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy
NCT03592004Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer
NCT07286695Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
NCT04821765Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
NCT06861777Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
NCT05983107Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
NCT07117864Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
NCT06577961Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
NCT07099794A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen
NCT03874871Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT07186621Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
NCT06987500A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment
NCT06245824Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial
NCT02635503Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer
NCT07187154The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy